RxElite, Inc.
OTC: RXEI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Richard Tener
- Employees
- 47
- Headquarters
- Meridian, United States
- IPO year
- 2020
- Market cap
- $1.5K
- Website
- https://www.piramalcriticalcare.com
Loading RXEI…
Loading profile data…Frequently asked questions about RXEI
What does RxElite, Inc. (RXEI) do?
RxElite, Inc. is a pharmaceutical company that specializes in the development, production, and commercialization of generic prescription drugs, particularly within specialty markets. Its diverse product portfolio encompasses Sterile Liquid Dose offerings, such as generic ophthalmic solutions (available in both unit-dose and multi-dose formats),...
Where does RXEI trade?
RxElite, Inc. (RXEI) trades on the Other OTC.
What sector is RXEI in?
RxElite, Inc. (RXEI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of RxElite, Inc.?
Richard Tener is the chief executive officer of RxElite, Inc. (RXEI).
Where is RxElite, Inc. headquartered?
RxElite, Inc. is headquartered in United States.
Does RXEI pay a dividend?
RxElite, Inc. (RXEI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RXEI go public?
RxElite, Inc. (RXEI) completed its initial public offering in 2020.